RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTYX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ventyx Biosciences, Inc. stock price fell more than -5.31% Tuesday closing at $2.14
(Updated on Jul 02, 2024)

Sell candidate since Jun 06, 2024 Loss -34.86% PDF

The Ventyx Biosciences, Inc. stock price fell by -5.31% on the last day (Tuesday, 2nd Jul 2024) from $2.26 to $2.14. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.16% from a day low at $2.13 to a day high of $2.24. The price has fallen in 7 of the last 10 days and is down by -22.18% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -232 thousand shares and in total, 623 thousand shares were bought and sold for approximately $1.33 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.15) are considered to be a "second chance" to get out. According to the fan-theory -$0.311 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTYX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ventyx Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.33 and $3.68. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 05, 2024, and so far it has fallen -59.47%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Ventyx Biosciences, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 5.16%. For the last week the stock has had daily average volatility of 6.71%.

Ventyx Biosciences, Inc. is oversold on RSI14 (7). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTYX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Ventyx Biosciences, Inc. to open at $2.17, and during the day (based on 14 day Average True Range), to move between $1.84 and $2.44, which gives a possible trading interval of +/-$0.299 (+/-13.99%) up or down from last closing price. If Ventyx Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 27.99% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.31, some $0.170 (7.94%) from the current price of $2.14, our system finds the risk reward not very attractive.

Is Ventyx Biosciences, Inc. stock A Buy?

Ventyx Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.823 Strong Sell Candidate Unchanged

Predicted Opening Price for Ventyx Biosciences, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$2.17 ( 1.40%) $2.14

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTYX

Fibonacci Support & Resistance Levels

Level Price
R3 2.28 6.54%
R2 2.24 4.58%
R1 2.21 3.37%
Price 2.14
S1 2.13 -0.562%
S2 2.10 -1.77%
S3 2.06 -3.74%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.51 17.29%
R2 2.39 11.68%
R1 2.31 7.94%
Price 2.14
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Ventyx Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Ventyx Biosciences, Inc. is VTYX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ventyx Biosciences, Inc. Stock?
Ventyx Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Ventyx Biosciences, Inc. Stock?
Ventyx Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ventyx Biosciences, Inc. Stock.

What's the current price of Ventyx Biosciences, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Ventyx Biosciences, Inc. (VTYX) share was $2.14.

What is the 52-week high and low for Ventyx Biosciences, Inc. Stock?
The 52-week high for Ventyx Biosciences, Inc. Stock is $40.58 and the 52-week low is $1.87.

What is the market capitalization of Ventyx Biosciences, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Ventyx Biosciences, Inc. is 159.328M.

When is the next earnings date for Ventyx Biosciences, Inc.?
The upcoming earnings date for Ventyx Biosciences, Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Ventyx Biosciences, Inc.

Ventyx Biosciences. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002,... VTYX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT